Corrigendum to “Human induced pluripotent stem cells generated from a patient with a homozygous mutation in the Lyn kinase gene” [Stem Cell Res. 64 (2022) 102933]

• Rebecca Harper,
• Quan Yu,
• Yangtenyu Liu,
• Dan Yang,
• Jizhong Zou,
• Jeanette Beers,
• Adriana A de Jesus Rasheed,
• Raphaela Goldbach-Mansky,
• Manfred Boehm,
• Guibin Chen

Affiliations

Rebecca Harper

Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Quan Yu

Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Yangtenyu Liu

Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA; Department of Rheumatology and Immunology, Xiangya Hospital, Central South University, Changsha, China

Dan Yang

Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Jizhong Zou

Induced Pluripotent Stem Cells (iPSC) Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Jeanette Beers

Induced Pluripotent Stem Cells (iPSC) Core, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Adriana A de Jesus Rasheed

Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA

Raphaela Goldbach-Mansky

Inflammatory Disease Section, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA

Manfred Boehm

Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA

Guibin Chen

Translational Vascular Medicine Branch, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, MD 20892, USA; Corresponding author.